| 1 |
Kapoor B, Gulati M, Gupta R, Singla RK. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome? Autoimmun Rev 2023;22:103313. [PMID: 36918089 DOI: 10.1016/j.autrev.2023.103313] [Reference Citation Analysis]
|
| 2 |
Yang B, Xiong Z, Lin M, Yang Y, Chen Y, Zeng J, Jia X, Feng L. Astragalus polysaccharides alleviate type 1 diabetes via modulating gut microbiota in mice. Int J Biol Macromol 2023;234:123767. [PMID: 36812962 DOI: 10.1016/j.ijbiomac.2023.123767] [Reference Citation Analysis]
|
| 3 |
Rosell-mases E, Santiago A, Corral-pujol M, Yáñez F, Varela E, Egia-mendikute L, Arpa B, Cosovanu C, Panosa A, Mora C, Verdaguer J, Manichanh C. Mutual Modulation of Gut Microbiota and the Immune System in Type 1 Diabetes Models.. [DOI: 10.21203/rs.3.rs-2512837/v1] [Reference Citation Analysis]
|
| 4 |
SeyedAlinaghi S, Afzalian A, Pashaei Z, Varshochi S, Karimi A, Mojdeganlou H, Mojdeganlou P, Razi A, Ghanadinezhad F, Shojaei A, Amiri A, Dashti M, Ghasemzadeh A, Dadras O, Mehraeen E, Afsahi AM. Gut microbiota and COVID-19: A systematic review. Health Sci Rep 2023;6:e1080. [PMID: 36721396 DOI: 10.1002/hsr2.1080] [Reference Citation Analysis]
|
| 5 |
Kunath BJ, Hickl O, Queirós P, Martin-Gallausiaux C, Lebrun LA, Halder R, Laczny CC, Schmidt TSB, Hayward MR, Becher D, Heintz-Buschart A, de Beaufort C, Bork P, May P, Wilmes P. Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analyses. Microbiome 2022;10:243. [PMID: 36578059 DOI: 10.1186/s40168-022-01435-4] [Reference Citation Analysis]
|
| 6 |
Rojas A, Schneider I, Lindner C, Gonzalez I, Morales MA. Association between diabetes and cancer. Current mechanistic insights into the association and future challenges. Mol Cell Biochem 2022. [DOI: 10.1007/s11010-022-04630-x] [Reference Citation Analysis]
|
| 7 |
Levi Mortera S, Marzano V, Vernocchi P, Matteoli MC, Guarrasi V, Gardini S, Del Chierico F, Rapini N, Deodati A, Fierabracci A, Cianfarani S, Putignani L. Functional and Taxonomic Traits of the Gut Microbiota in Type 1 Diabetes Children at the Onset: A Metaproteomic Study. Int J Mol Sci 2022;23. [PMID: 36555624 DOI: 10.3390/ijms232415982] [Reference Citation Analysis]
|
| 8 |
Del Chierico F, Rapini N, Deodati A, Matteoli MC, Cianfarani S, Putignani L. Pathophysiology of Type 1 Diabetes and Gut Microbiota Role. Int J Mol Sci 2022;23. [PMID: 36498975 DOI: 10.3390/ijms232314650] [Reference Citation Analysis]
|
| 9 |
Mousa WK, Chehadeh F, Husband S. Microbial dysbiosis in the gut drives systemic autoimmune diseases. Front Immunol 2022;13:906258. [DOI: 10.3389/fimmu.2022.906258] [Reference Citation Analysis]
|
| 10 |
Zhang B, Jin Z, Zhai T, Ding Q, Yang H, Wang J, Zhang L, Zhao L. Global research trends on the links between the gut microbiota and diabetes between 2001 and 2021: A bibliometrics and visualized study. Front Microbiol 2022;13:1011050. [DOI: 10.3389/fmicb.2022.1011050] [Reference Citation Analysis]
|
| 11 |
Zemanova N, Omelka R, Mondockova V, Kovacova V, Martiniakova M. Roles of Gut Microbiome in Bone Homeostasis and Its Relationship with Bone-Related Diseases. Biology 2022;11:1402. [DOI: 10.3390/biology11101402] [Reference Citation Analysis]
|
| 12 |
de Cuevillas B, Riezu-Boj JI, Abete I, Zulet MA, Galarregui C, Gonzalez-Navarro CJ, Milagro FI, Martínez JA, Navas-Carretero S. Possible metabolic interplay between quality of life and fecal microbiota in a presenior population-Preliminary results. Nutrition 2022;103-104:111841. [PMID: 36183483 DOI: 10.1016/j.nut.2022.111841] [Reference Citation Analysis]
|
| 13 |
Elsherbiny NM, Ramadan M, Abu Faddan NH, Hassan EA, Ali ME, Abd El-Rehim ASE, Abbas WA, Abozaid MAA, Hassanin E, Mohamed GA, Hetta HF, Salah M. Impact of Geographical Location on the Gut Microbiota Profile in Egyptian Children with Type 1 Diabetes Mellitus: A Pilot Study. Int J Gen Med 2022;15:6173-87. [PMID: 35864993 DOI: 10.2147/IJGM.S361169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Thakur PS, Aggarwal D, Takkar B, Shivaji S, Das T. Evidence Suggesting the Role of Gut Dysbiosis in Diabetic Retinopathy. Invest Ophthalmol Vis Sci 2022;63:21. [PMID: 35877085 DOI: 10.1167/iovs.63.8.21] [Reference Citation Analysis]
|
| 15 |
Rodrigues VF, Elias-oliveira J, Pereira ÍS, Pereira JA, Barbosa SC, Machado MSG, Carlos D. Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Front Immunol 2022;13:934695. [DOI: 10.3389/fimmu.2022.934695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Farsi Y, Tahvildari A, Arbabi M, Vazife F, Sechi LA, Shahidi Bonjar AH, Jamshidi P, Nasiri MJ, Mirsaeidi M. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review. Front Cell Infect Microbiol 2022;12:804644. [DOI: 10.3389/fcimb.2022.804644] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 17 |
Dovi KS, Bajinka O, Conteh I. Evidence and possible mechanisms of probiotics in the management of type 1 diabetes mellitus. J Diabetes Metab Disord 2022;21:1081-94. [PMID: 35673472 DOI: 10.1007/s40200-022-01006-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Kunath B, Hickl O, Queirós P, Martin-gallausiaux C, Lebrun L, Halder R, Laczny C, Schmidt T, Hayward M, Becher D, Heintz-buschart A, de Beaufort C, Bork P, May P, Wilmes P. Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by multi-omic analysis.. [DOI: 10.1101/2022.02.13.480246] [Reference Citation Analysis]
|
| 19 |
Craciun C, Neag M, Catinean A, Mitre A, Rusu A, Bala C, Roman G, Buzoianu A, Muntean D, Craciun A. The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus. Biomedicines 2022;10:308. [DOI: 10.3390/biomedicines10020308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 20 |
Xia H, Shi X, Zhou B, Sui J, Yang C, Liu H, Yang L, Wang S, Sun G. Milled flaxseed-added diets ameliorated hepatic inflammation by reducing gene expression of TLR4/NF-κB pathway and altered gut microbiota in STZ-induced type 1 diabetic mice. Food Science and Human Wellness 2022;11:32-40. [DOI: 10.1016/j.fshw.2021.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Nie K, Ma K, Luo W, Shen Z, Yang Z, Xiao M, Tong T, Yang Y, Wang X. Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species. Front Cell Infect Microbiol 2021;11:757718. [PMID: 34881193 DOI: 10.3389/fcimb.2021.757718] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 22 |
Chen LL, Abbaspour A, Mkoma GF, Bulik CM, Rück C, Djurfeldt D. Gut Microbiota in Psychiatric Disorders: A Systematic Review. Psychosom Med 2021;83:679-92. [PMID: 34117156 DOI: 10.1097/PSY.0000000000000959] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 23 |
Al Rijjal D, Liu Y, Lai M, Song Y, Danaei Z, Wu A, Mohan H, Wei L, Schopfer FJ, Dai FF, Wheeler MB. Vascepa protects against high-fat diet-induced glucose intolerance, insulin resistance, and impaired β-cell function. iScience 2021;24:102909. [PMID: 34458694 DOI: 10.1016/j.isci.2021.102909] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 24 |
Ternák G, Berényi K, Kun S, Szigeti N, Decsi T, Sütő G, Wittmann I. Inverse association between use of broad spectrum penicllin with beta-lactamase inhibitors and prevalence of type 1 diabetes mellitus in Europe. Sci Rep 2021;11:16768. [PMID: 34408224 DOI: 10.1038/s41598-021-96301-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 25 |
Yuan X, Chang C, Chen X, Li K. Emerging trends and focus of human gastrointestinal microbiome research from 2010-2021: a visualized study. J Transl Med 2021;19:327. [PMID: 34332587 DOI: 10.1186/s12967-021-03009-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 26 |
Uchida A, Yasuma T, Takeshita A, Toda M, Okano Y, Nishihama K, D'Alessandro-Gabazza CN, Fridman D'Alessandro V, Inoue C, Takagi T, Mukaiyama H, Takagi N, Shimizu K, Yano Y, Gabazza EC. Oral Limonite Supplement Ameliorates Glucose Intolerance in Diabetic and Obese Mice. J Inflamm Res 2021;14:3089-105. [PMID: 34276223 DOI: 10.2147/JIR.S320451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 27 |
Foresto-Neto O, Ghirotto B, Câmara NOS. Renal Sensing of Bacterial Metabolites in the Gut-kidney Axis. Kidney360 2021;2:1501-9. [PMID: 35373097 DOI: 10.34067/KID.0000292021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Groele L, Szajewska H, Szalecki M, Świderska J, Wysocka-Mincewicz M, Ochocińska A, Stelmaszczyk-Emmel A, Demkow U, Szypowska A. Lack of effect of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: a randomised controlled trial. BMJ Open Diabetes Res Care 2021;9:e001523. [PMID: 33771763 DOI: 10.1136/bmjdrc-2020-001523] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 29 |
Zhao H, Wu H, Duan M, Liu R, Zhu Q, Zhang K, Wang L. Cinnamaldehyde Improves Metabolic Functions in Streptozotocin-Induced Diabetic Mice by Regulating Gut Microbiota. Drug Des Devel Ther 2021;15:2339-55. [PMID: 34103897 DOI: 10.2147/DDDT.S288011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 30 |
Talukdar R, Sarkar P, Jakkampudi A, Sarkar S, Aslam M, Jandhyala M, Deepika G, Unnisa M, Reddy DN. The gut microbiome in pancreatogenic diabetes differs from that of Type 1 and Type 2 diabetes. Sci Rep 2021;11:10978. [PMID: 34040023 DOI: 10.1038/s41598-021-90024-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 31 |
Du X, Liu J, Xue Y, Kong X, Lv C, Li Z, Huang Y, Wang B. Alteration of gut microbial profile in patients with diabetic nephropathy. Endocrine 2021;73:71-84. [PMID: 33905112 DOI: 10.1007/s12020-021-02721-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 32 |
Gradisteanu Pircalabioru G, Corcionivoschi N, Gundogdu O, Chifiriuc MC, Marutescu LG, Ispas B, Savu O. Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies. Int J Mol Sci 2021;22:2763. [PMID: 33803255 DOI: 10.3390/ijms22052763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 33 |
Liu W, Zhou Y, Sun H, Li R, Qin Y, Yu L, Chen Y, Li Y, Tan Y, Zhao R, Zhang W, Jiang S, Xu Y. Goat Milk Improves Glucose Homeostasis via Enhancement of Hepatic and Skeletal Muscle AMP-Activated Protein Kinase Activation and Modulation of Gut Microbiota in Streptozocin-Induced Diabetic Rats. Mol Nutr Food Res 2021;65:e2000888. [PMID: 33555137 DOI: 10.1002/mnfr.202000888] [Reference Citation Analysis]
|
| 34 |
Knudsen JK, Leutscher P, Sørensen S. Gut Microbiota in Bone Health and Diabetes. Curr Osteoporos Rep 2021;19:462-79. [PMID: 33523423 DOI: 10.1007/s11914-020-00629-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 35 |
Yap YA, Mariño E. Dietary SCFAs Immunotherapy: Reshaping the Gut Microbiota in Diabetes. Adv Exp Med Biol 2021;1307:499-519. [PMID: 32193865 DOI: 10.1007/5584_2020_515] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 36 |
Xu HM, Huang HL, Zhou YL, Zhao HL, Xu J, Shou DW, Liu YD, Zhou YJ, Nie YQ. Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain. Gastroenterol Res Pract 2021;2021:6699268. [PMID: 33510784 DOI: 10.1155/2021/6699268] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 37 |
Calabrese CM, Valentini A, Calabrese G. Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet. Front Nutr 2020;7:612773. [PMID: 33521039 DOI: 10.3389/fnut.2020.612773] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 38 |
Witjes VM, Boleij A, Halffman W. Reducing versus Embracing Variation as Strategies for Reproducibility: The Microbiome of Laboratory Mice. Animals (Basel) 2020;10:E2415. [PMID: 33348632 DOI: 10.3390/ani10122415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 39 |
Passos FC, Gois MB, Sousa AD, de Marinho AIL, Corvo L, Soto M, Barral-Netto M, Barral A, Baccan GC. Investigating associations between intestinal alterations and parasite load according to Bifidobacterium spp. and Lactobacillus spp. abundance in the gut microbiota of hamsters infected by Leishmania infantum. Mem Inst Oswaldo Cruz 2020;115:e200377. [PMID: 33263602 DOI: 10.1590/0074-02760200377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Jadhav K, Cohen TS. Can You Trust Your Gut? Front Endocrinol (Lausanne). 2020;11:592157. [PMID: 33193105 DOI: 10.3389/fendo.2020.592157] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 41 |
Mondanelli G, Orecchini E, Volpi C, Panfili E, Belladonna ML, Pallotta MT, Moretti S, Galarini R, Esposito S, Orabona C. Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients. Int J Tryptophan Res 2020;13:1178646920956646. [PMID: 33061415 DOI: 10.1177/1178646920956646] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 42 |
Mojsak P, Rey-Stolle F, Parfieniuk E, Kretowski A, Ciborowski M. The role of gut microbiota (GM) and GM-related metabolites in diabetes and obesity. A review of analytical methods used to measure GM-related metabolites in fecal samples with a focus on metabolites' derivatization step. J Pharm Biomed Anal 2020;191:113617. [PMID: 32971497 DOI: 10.1016/j.jpba.2020.113617] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 43 |
Elias-Oliveira J, Leite JA, Pereira ÍS, Guimarães JB, Manso GMDC, Silva JS, Tostes RC, Carlos D. NLR and Intestinal Dysbiosis-Associated Inflammatory Illness: Drivers or Dampers? Front Immunol 2020;11:1810. [PMID: 32903730 DOI: 10.3389/fimmu.2020.01810] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 44 |
Fenneman AC, Rampanelli E, Yin YS, Ames J, Blaser MJ, Fliers E, Nieuwdorp M. Gut microbiota and metabolites in the pathogenesis of endocrine disease. Biochemical Society Transactions 2020;48:915-31. [DOI: 10.1042/bst20190686] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 45 |
Predieri B, Bruzzi P, Bigi E, Ciancia S, Madeo SF, Lucaccioni L, Iughetti L. Endocrine Disrupting Chemicals and Type 1 Diabetes. Int J Mol Sci. 2020;21. [PMID: 32331412 DOI: 10.3390/ijms21082937] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 46 |
Vendrik KEW, Ooijevaar RE, de Jong PRC, Laman JD, van Oosten BW, van Hilten JJ, Ducarmon QR, Keller JJ, Kuijper EJ, Contarino MF. Fecal Microbiota Transplantation in Neurological Disorders. Front Cell Infect Microbiol 2020;10:98. [PMID: 32266160 DOI: 10.3389/fcimb.2020.00098] [Cited by in Crossref: 110] [Cited by in F6Publishing: 121] [Article Influence: 36.7] [Reference Citation Analysis]
|
| 47 |
Yang Z. Is fecal microbiota transplantation a promising strategy for type 2 diabetes mellitus? EMIJ 2020;8. [DOI: 10.15406/emij.2020.08.00275] [Reference Citation Analysis]
|
| 48 |
Galloway-Peña J, Hanson B. Tools for Analysis of the Microbiome. Dig Dis Sci 2020;65:674-85. [PMID: 32002757 DOI: 10.1007/s10620-020-06091-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 49 |
Zhang P, Minardi LM, Kuenstner JT, Zhang ST, Zekan SM, Kruzelock R. Serological Testing for Mycobacterial Heat Shock Protein Hsp65 Antibody in Health and Diseases. Microorganisms 2019;8:E47. [PMID: 31881708 DOI: 10.3390/microorganisms8010047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
